Publication Details

Category Text Publication
Reference Category Journals
DOI 10.1177/026119299802601s03
Title (Primary) MEIC evaluation of acute systemic toxicity - Part IV. In vitro results from 67 toxicity assays used to test reference chemicals 31-50 and a comparative cytotoxicity analysis
Author Clemedson, C.; Andersson, M.; Aoki, Y.; Barile, F.A.; Bassi, A.M.; Calleja, M.C.; Castano, A.; Clothier, R.H.; Dierickx, P.; Ekwall, B.; Ferro, M.; Fiskesjö, G.; Garza-Ocanas, L.; Gómez-Lechón, M.J.; Gülden, M.; Hall, T.; Imai, K.; Isomaa, B.; Kahru, A.; Kerszman, G.; Kjellstrand, P.; Kristen, U.; Kunimoto, M.; Kärenlampi, S.; Lewan, L.; Lilius, H.; Loukianov, A.; Monaco, F.; Ohno, T.; Persoone, G.; Romert, L.; Sawyer, T.W.; Segner, H.; Seibert, H.; Shrivastava, R.; Sjöström, M.; Stammati, A.; Tanaka, N.; Thuvander, A.; Torres-Alanis, O.; Valentino, M.; Wakuri, S.; Walum, E.; Wang, X.H.; Wieslander, A.; Zucco, F.; Ekwall, B.
Journal ATLA-Alternatives to Laboratory Animals
Year 1998
Department OEC; COE
Volume 26
Page From 131
Page To 183
Language englisch
Abstract Results from tests on the Multicentre Evaluation of In Vitro Cytotoxicity (MEIC) reference chemicals 31–50 in 67 different in vitro toxicity assays are presented in this paper as a prerequisite to in vitro/in vivo comparisons for all MEIC in vitro toxicity data in forthcoming papers, i.e. the final MEIC evaluation of the relevance of the tests. With the aim of increasing knowledge about the relative significance of some in vitro methodological factors, the strategies and methods of the preceding parts in the MEIC series (Parts II and III) were again employed to enable comparative cytotoxicity analysis of the new in vitro results presented in this paper. A principal components analysis (PCA) of the results from tests of the 20 chemicals in 67 assays demonstrated a dominating first component describing as much as 74% of the variance in the toxicity data, indicating a similar ranking of the cytotoxicities of the chemicals in most of the tests. The influence on the general variability of the results of a few, key methodological factors was also evaluated by using linear regression comparisons of the results of all pairs of methods available in the study, i.e. methods which were similar in all respects except for the factor being analysed. Results from this “random probe” analysis were: a) the cytotoxicities of 11 of the 20 chemicals increased considerably with exposure time (> 10 times over 4–168 hours); b) in general, human cell line toxicity was well predicted by cytotoxicity in animal cells; c) prediction of human cell line toxicity by most ecotoxicological tests was only fairly good; d) 14 comparisons of similar assays with different cell lines showed similar toxicities (mean R2 = 0.83); e) nine comparisons of similar assays employing different primary cultures and cell lines shared similar toxicities (mean R2 = 0.71); and f) 16 comparisons of similar assays with different growth/viability endpoints showed similar toxicities (mean R2 = 0.71). Results b, d, e and f must contribute to the PCA-documented high general similarity of the in vitro toxicity data. Results a and c, together with factors which were not analysed, such as different protocols and inter-laboratory variability of tests, could explain the 26% dissimilarity. To provide background information to the planned final MEIC evaluation of the relevance of the 61 methods in which all 50 chemicals have been tested, an additional PCA was made of the 50 chemical-61 assay in vitro database (from Parts II and III and the present paper). This supplementary PCA demonstrated an 80% similarity of results. Compared with the previous analysis of the tests of the first 30 MEIC reference chemicals (MEIC Part III), the present analysis of the tests of the last 20 MEIC chemicals indicates a somewhat higher variation in the results. Correspondingly, some deviating endpoint measurements and cell line responses were demonstrated by the pairwise comparisons in the present study. As a result, the analysis revealed a high correlation (R2 = 0.73) between the average human cell line toxicity and the results from a new protein denaturation test. These preliminary results suggest that intracellular protein denaturation may be a frequently occurring mechanism in basal cytotoxicity.
Persistent UFZ Identifier
Clemedson, C., Andersson, M., Aoki, Y., Barile, F.A., Bassi, A.M., Calleja, M.C., Castano, A., Clothier, R.H., Dierickx, P., Ekwall, B., Ferro, M., Fiskesjö, G., Garza-Ocanas, L., Gómez-Lechón, M.J., Gülden, M., Hall, T., Imai, K., Isomaa, B., Kahru, A., Kerszman, G., Kjellstrand, P., Kristen, U., Kunimoto, M., Kärenlampi, S., Lewan, L., Lilius, H., Loukianov, A., Monaco, F., Ohno, T., Persoone, G., Romert, L., Sawyer, T.W., Segner, H., Seibert, H., Shrivastava, R., Sjöström, M., Stammati, A., Tanaka, N., Thuvander, A., Torres-Alanis, O., Valentino, M., Wakuri, S., Walum, E., Wang, X.H., Wieslander, A., Zucco, F., Ekwall, B. (1998):
MEIC evaluation of acute systemic toxicity - Part IV. In vitro results from 67 toxicity assays used to test reference chemicals 31-50 and a comparative cytotoxicity analysis
ATLA-Altern. Lab. Anim. 26 , 131 - 183